lancet-header

Preprints with The Lancet is part of SSRN´s First Look, a place where journals identify content of interest prior to publication. Authors have opted in at submission to The Lancet family of journals to post their preprints on Preprints with The Lancet. The usual SSRN checks and a Lancet-specific check for appropriateness and transparency have been applied. Preprints available here are not Lancet publications or necessarily under review with a Lancet journal. These preprints are early stage research papers that have not been peer-reviewed. The findings should not be used for clinical or public health decision making and should not be presented to a lay audience without highlighting that they are preliminary and have not been peer-reviewed. For more information on this collaboration, see the comments published in The Lancet about the trial period, and our decision to make this a permanent offering, or visit The Lancet´s FAQ page, and for any feedback please contact preprints@lancet.com.

Comparative Validation of Three DNA Methylation Algorithms of Ageing and a Frailty Index in Relation to Mortality: Results From the ESTHER Cohort Study

20 Pages Posted: 26 May 2021

See all articles by Xiangwei Li

Xiangwei Li

German Cancer Research Center (DKFZ) - Division of Clinical Epidemiology and Aging Research

Yan Zhang

German Cancer Research Center (DKFZ) - Division of Clinical Epidemiology and Aging Research

Xīn Gào

German Cancer Research Center (DKFZ) - Division of Clinical Epidemiology and Aging Research

Bernd Holleczek

Saarland Cancer Registry

Ben Schöttker

German Cancer Research Center (DKFZ) - Division of Clinical Epidemiology and Aging Research

Hermann Brenner

German Cancer Research Center (DKFZ) - Division of Clinical Epidemiology and Aging Research

More...

Abstract

Background: Three DNA methylation (DNAm) based algorithms, DNAm PhenoAge acceleration (AgeAccelPheno), DNAm GrimAge acceleration (AgeAccelGrim), and mortality risk score (MRscore), based on methylation in 513, 1030 and 10 CpG sites, respectively, were recently established to predict health outcomes and mortality. We aimed to compare and validate the predictive ability of these scores and frailty in relation to mortality in a population-based cohort of older adults (50-75 years at baseline) from Germany.

Methods: DNA methylation in whole blood was measured by the Infinium Methylation EPIC BeadChip kit (EPIC, Illumina, San Diego, CA, USA) and used to calculate the three methylation algorithms in two random subsets of the ESTHER cohort study (n = 741 and n = 1030). Frailty was assessed by a frailty index (FI) based on percentage of 34 selected deficits. 

Findings: During 14 years of follow-up, a total of 346 deaths were observed. AgeAccelPheno, AgeAccelGrim, MRscore and FI were positively correlated. Although each of them was strongly and independently associated with mortality, the association was strongest for MRscore [adjusted hazard ratio (95% CI) per SD increase = 1·73 (1·46-2·06]. Harrell’s C-statistic was 0·706 for a model predicting mortality by age and sex alone and increased to 0·752 in a model including MRscore and the FI.

Interpretation: The combination of a DNA methylation score based on 10 CpGs only and an easy to ascertain frailty index may strongly enhance mortality prediction beyond age and sex.

Funding Information: The ESTHER study was funded by grants from the Baden-Württemberg state Ministry of Science, Research and Arts (Stuttgart, Germany), the Federal Ministry of Education and Research (Berlin, Germany), the Federal Ministry of Family Affairs, Senior Citizens, Women and Youth (Berlin, Germany), and the Saarland State Ministry of Health, Social Affairs, Women and the Family (Saarbrücken, Germany).

Declaration of Interests: No potential conflicts of interest were disclosed.

Ethics Approval Statement: The ESTHER study was approved by the ethics committees of the medical faculty of the University of Heidelberg and the medical board of the state of Saarland. Written informed consent was obtained from each participant.

Keywords: DNA methylation; epigenetic clock; age acceleration; frailty; mortality

Suggested Citation

Li, Xiangwei and Zhang, Yan and Gào, Xīn and Holleczek, Bernd and Schöttker, Ben and Brenner, Hermann, Comparative Validation of Three DNA Methylation Algorithms of Ageing and a Frailty Index in Relation to Mortality: Results From the ESTHER Cohort Study. Available at SSRN: https://ssrn.com/abstract=3845378 or http://dx.doi.org/10.2139/ssrn.3845378

Xiangwei Li (Contact Author)

German Cancer Research Center (DKFZ) - Division of Clinical Epidemiology and Aging Research ( email )

Heidelberg
Germany

Yan Zhang

German Cancer Research Center (DKFZ) - Division of Clinical Epidemiology and Aging Research

Heidelberg
Germany

Xīn Gào

German Cancer Research Center (DKFZ) - Division of Clinical Epidemiology and Aging Research ( email )

Heidelberg
Germany

Bernd Holleczek

Saarland Cancer Registry

Ben Schöttker

German Cancer Research Center (DKFZ) - Division of Clinical Epidemiology and Aging Research

Im Neuenheimer Feld 280
Heidelberg, 69120
Germany

Hermann Brenner

German Cancer Research Center (DKFZ) - Division of Clinical Epidemiology and Aging Research ( email )

Heidelberg
Germany

Click here to go to TheLancet.com

Paper statistics

Downloads
41
Abstract Views
266
PlumX Metrics